Galectin-3: A New Target For Inflammation with Dr Issac Eliaz

Published: March 4, 2020, 1 p.m.

What is Galectin-3 and how is it connected to disease?\n Galectin-3 (Gal-3) is a protein that modulates an array of biochemical processes in the body and is becoming increasingly implicated in the development of a multitude of diseases,\xa0including cancer, fibrosis,\xa0and metabolic diseases. But what if there was a way to lower levels of Galectin-3 with a natural compound? Today we welcome clinician and researcher, Dr Isaac Eliaz who shares with us his research on modified citrus pectin (MCP) and how,\xa0through influencing Gal-3,\xa0it has the potential to be applied to a broad range of inflammatory diseases. Dr Eliaz also discusses his passion for\xa0the profound effects of\xa0mind-body medicine practices,\xa0including how\xa0meditation\xa0can\xa0influence Gal-3 and improve wellbeing. \n\nFind today's show notes and transcript here: https://www.fxmedicine.com.au/podcast/galectin-3-new-target-inflammation-dr-isaac-eliaz \n\n *****DISCLAIMER: The information provided on FX Medicine is for educational and informational purposes only. The information provided is not, nor is it intended to be, a substitute for professional advice or care. Please seek the advice of a qualified health care professional in the event something you learn here raises questions or concerns regarding your health.*****